SCHEMBL20360337

SCHEMBL20360337

CCOC(=O)c1cnc2n1CCOC2

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
IDO1 P14902 5/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 2/20 0.39
ALDH1A1 P00352 2/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALOX15 P16050 1/20 0.39
PKM P14618 1/20 0.39
TSHR P16473 1/20 0.39
USP2 O75604 1/20 0.38
TP53 P04637 1/20 0.38
MAPK1 P28482 1/20 0.38
RECQL P46063 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CASP7 P55210 1/20 0.38
CASP6 P55212 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18365809 0.78 POLB (0.41) PIK3CAKDM4ELMNAALDH1A1RAB9A
Hydrochloric Acid SCHEMBL21818893 0.77 POLB (0.41) PIK3CAKDM4ELMNAALDH1A1RAB9A
SCHEMBL14962437 0.76 MGLL (0.41) IDO1LMNAALDH1A1
SCHEMBL17454164 0.75 DPP4 (0.41) PIK3CAL3MBTL1KDM4ELMNAALDH1A1
SCHEMBL17579506 0.75 MAPT (0.39) L3MBTL1IDO1KDM4EALDH1A1RAB9A
SCHEMBL30236815 0.75 DRD3 (0.43) IDO1KDM4ELMNAALDH1A1RAB9A
SCHEMBL23144554 0.74 ALDH1A1 (0.49) IDO1LMNAALDH1A1RAB9ASMN1; SMN2
SCHEMBL17591384 0.72 KCNK3 (0.47) ALDH1A1
SCHEMBL31714780 0.72 POLB (0.44) PIK3CAL3MBTL1KDM4ELMNAALDH1A1
SCHEMBL24692798 0.71 IDO1 (0.35) IDO1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10196385-B2 Tetrahydropyranyl benzamide derivatives ELI LILLY AND COMPANY (US) 2019-02-05 US disclosed
US-10196385-B2 Tetrahydropyranyl benzamide derivatives ELI LILLY AND COMPANY (US) 2019-02-05 US disclosed
US-20180194755-A1 Tetrahydropyranyl Benzamide Derivatives ELI LILLY AND COMPANY 2018-07-12 US disclosed
US-20180194755-A1 Tetrahydropyranyl Benzamide Derivatives ELI LILLY AND COMPANY 2018-07-12 US disclosed
US-20180194755-A1 Tetrahydropyranyl Benzamide Derivatives ELI LILLY AND COMPANY 2018-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10196385-B2 Tetrahydropyranyl benzamide derivatives INSR, GPR119, GLP1R PIK3CA 2770/4885L3MBTL1 2591/4885IDO1 2719/4885
US-20180194755-A1 Tetrahydropyranyl Benzamide Derivatives INSR, GPR119, GLP1R PIK3CA 2893/4885L3MBTL1 3076/4885IDO1 3030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.